1. Chew C, Craig L, Edwards R, Moss J, O’Dwyer PJ. Safety and efficacy of percutaneous vertebroplasty in malignancy: a systematic review. Clin Radiol. 2011;66(1):63–72.
2. Makary MS, Zucker IL, Sturgeon JM. Venous extravasation and polymethylmethacrylate pulmonary embolism following fluoroscopy-guided percutaneous vertebroplasty. Acta Radiol Open. 2015;4(8):2058460115595660.
3. Chevallier M, Tsantoulis P, Addeo A, Friedlaender A. Influence of concurrent mutations on overall survival in EGFR-mutated non-small cell lung cancer. Cancer Genomics Proteomics. 2020;17(5):597–603.
4. Friedlaender A, Drilon A, Weiss GJ, Banna GL, Addeo A. KRAS as a druggable target in NSCLC: Rising like a phoenix after decades of development failures. Cancer Treat Rev. 2020;85:101978.
5. Torralvo J, Friedlaender A, Achard V, Addeo A. The activity of immune checkpoint inhibition in KRAS mutated non-small cell lung cancer: a single centre experience. Cancer Genomics Proteomics. 2019 Nov-Dec;16(6):577–82.